Table 1.
SNP
|
Outcome
|
Exposure
|
P val. exposure
|
rs10184004 | PCa | DM | 1.42E-10 |
rs10196106 | PCa | DM | 1.02E-12 |
rs10748582 | PCa | DM | 1.61E-18 |
rs10830963 | PCa | DM | 3.45E-14 |
rs10965247 | PCa | DM | 6.65E-26 |
rs11671304 | PCa | DM | 1.03E-08 |
rs11720108 | PCa | DM | 5.75E-10 |
rs1215470 | PCa | DM | 2.17E-14 |
rs1260326 | PCa | DM | 7.61E-13 |
rs12910361 | PCa | DM | 3.34E-08 |
rs1317548 | PCa | DM | 1.19E-08 |
rs13262861 | PCa | DM | 3.90E-12 |
rs1421085 | PCa | DM | 1.36E-22 |
rs145762933 | PCa | DM | 3.85E-11 |
rs1496653 | PCa | DM | 3.66E-10 |
rs1515110 | PCa | DM | 5.35E-11 |
rs1800961 | PCa | DM | 1.40E-09 |
rs1801212 | PCa | DM | 8.72E-18 |
rs2206277 | PCa | DM | 3.23E-08 |
rs2237895 | PCa | DM | 9.39E-17 |
rs231361 | PCa | DM | 4.68E-09 |
rs2947793 | PCa | DM | 1.52E-10 |
rs340882 | PCa | DM | 2.14E-09 |
rs34715063 | PCa | DM | 1.72E-08 |
rs34872471 | PCa | DM | 3.60E-151 |
rs3802177 | PCa | DM | 1.90E-19 |
rs3887925 | PCa | DM | 4.88E-09 |
rs41463147 | PCa | DM | 1.51E-08 |
rs464605 | PCa | DM | 2.08E-08 |
rs4688760 | PCa | DM | 1.03E-08 |
rs4727554 | PCa | DM | 4.59E-09 |
rs5215 | PCa | DM | 1.49E-10 |
rs6885132 | PCa | DM | 2.60E-09 |
rs697239 | PCa | DM | 5.00E-12 |
rs7018475 | PCa | DM | 3.02E-14 |
rs7183842 | PCa | DM | 1.15E-08 |
rs7258722 | PCa | DM | 3.37E-08 |
rs72802365 | PCa | DM | 2.26E-11 |
rs75199135 | PCa | DM | 4.11E-08 |
rs757855 | PCa | DM | 1.83E-08 |
rs7646519 | PCa | DM | 7.02E-27 |
rs76895963 | PCa | DM | 3.07E-23 |
rs7766070 | PCa | DM | 4.38E-26 |
rs8118848 | PCa | DM | 2.38E-08 |
rs849142 | PCa | DM | 3.31E-15 |
rs9267659 | PCa | DM | 4.84E-15 |
rs9379084 | PCa | DM | 6.03E-13 |
rs9410573 | PCa | DM | 1.04E-13 |
rs9667947 | PCa | DM | 2.55E-11 |
DM: Diabetes mellitus; SNP: Single nucleotide polymorphism; PCa: Prostate cancer.